On the basis of this possible neuroprotective effect, GLP1 is currently under investigation as a potential disease-modifying treatment for AD; it could promote cell differentiation, neurogenesis, synaptic plasticity, attenuating oxidative stress and mitochondrial dysfunction, inhibiting neuronal apoptosis and neurotoxicity [43]. This evidence concerns the gene GCG and Alzheimer disease.